Status:
RECRUITING
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Bone Sarcoma
Osteosarcoma
Eligibility:
All Genders
4+ years
Brief Summary
The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who have tumor surgery plu...
Eligibility Criteria
Inclusion
- All patients undergoing reconstructive surgery for neoplasms involving bone on the orthopaedic surgery service at MSK
- Current or prior history of primary neoplasms involving osseous structures, including all subtypes
- Confirmation of diagnosis that has been performed by the MSK's Department of Pathology via direct review of tissue/slides
- Patients must read and understand English
- Age \>/=4
- Patients must read and understand English
Exclusion
- Patients that weight \<17 kilograms
Key Trial Info
Start Date :
February 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 14 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03442465
Start Date
February 14 2018
End Date
February 14 2026
Last Update
May 9 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Monmouth (Consent and Followup)
Middletown, New Jersey, United States, 07748
2
Memorial Sloan Kettering Westchester (Consent and Followup)
Harrison, New York, United States, 10604
3
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10021